Scandal In South Africa?
South Africa's Public Protector is probing whether Deputy President Thabo Mbeki and Health Minister Nkosazana Zuma acted unethically by urging that research resume on an anti-AIDS drug, Virodene. The opposition Democratic Party claims Pretoria-based Cryopreservation Technologies offered the ruling African National Congress a 6% stake in a unit that would hold patents on the drug.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.